Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYALOFAT: MFAT + HA vs MFAT in Bilateral Knee Osteoarthritis
NCT07121556Recruiting
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Sep 2025
- Primary completion
- Sep 2030
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 12 months. Started Sep 2025; status: recruiting.
02
Drugs
hyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07121556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07121556.